Kuros Biosciences AG/ CH0325814116 /
31/05/2024 16:48:04 | Chg. +0.49 | Volume | Bid17:19:00 | Ask17:20:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
9.21CHF | +5.62% | 2,307 Turnover: 20,808.16 |
-Bid Size: - | -Ask Size: - | 337.83 mill.CHF | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.38 CHF | -11.63% |
EPS Diluted: | - CHF | 65.22% |
Revenues per Share: | 0.92 CHF | 86.57% |
Book Value per Share: | 1.55 CHF | -17.64% |
Cash Flow per Share: | -0.24 CHF | 20.33% |
Dividend per Share: | - CHF | - |
Total | in mill. | |
Revenues: | 33.56 CHF | 86.57% |
Net Income: | -13.73 CHF | -5.98% |
Operating Cash Flow: | -8.84 CHF | - |
Cash and Cash Equivalents: | 14.21 CHF | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 10.07 | 3.80 |
P/BV ratio: | 5.96 | 2.25 |
P/CF Ratio: | -38.20 | -14.43 |
PEG: | 2.09 | - |
Earnings Yield: | -4.11% | -10.89% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 337.83 mill. CHF | 127.6 mill. CHF |
Free Float Market Cap.: | - CHF | - CHF |
Market Cap. / Employee: | 4.22 mill. CHF | 1.59 mill. CHF |
Shares Outstanding: | 36.56 mill. |
Profitability
Gross Profit Margin: | 71.31% |
EBIT Margin: | -39.30% |
Net Profit Margin: | -40.90% |
Return on Equity: | -24.20% |
Return on Assets: | -19.21% |
Financial Strength
Liquidity I / Cash Ratio: | 107.74% |
Liquidity II / Quick Ratio: | 156.36% |
Liquidity III / Current Ratio: | 206.22% |
Debt / Equity Ratio: | 26.01% |
Dynam. Debt / Equity Ratio: | -166.80% |
Efficiency
Employees: | 80 |
Personal Expenses / Employee: | - CHF |
Revenues / Employee: | 419,550.00 CHF |
Net Income / Employee: | -171,587.50 CHF |
Total Assets / Employee: | 893,300.00 CHF |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | IFRS |
Currency: | CHF |